Company news
Patrys Limited news in 2017
Patrys Limited's news releases, calls and decks from 2017, newest first.
PAT-DX1 is synergistic with PARP inhibitor
December 10, 2017
Collaboration with WEHI
November 15, 2017
Appendix 4C - Quarterly - 30 September 2017
October 27, 2017
PAB and Garvan Institute of Medical Research Awarded Grant
October 15, 2017
US Patent Granted for Preclinical Candidate PAT-LM1
October 11, 2017
PAT-DX1 Conjugated to Nanoparticles, Targets Tumors
September 17, 2017
PAT-DX1 Active in Pre-clinical Cancer Models
September 13, 2017
Appendix 4E and 2017 Annual Report
August 29, 2017
Appendix 4C - Quarterly - 30 June 2017
July 26, 2017
Patrys Deoxymab 3E10 patent granted in the U.S.
July 12, 2017
PAB Licences Deoxymab 3E10 - nanoparticle IP from Yale
June 12, 2017
Finance Update
April 30, 2017
Appendix 4C - Quarterly - 31 March 2017
April 26, 2017
Deoxymab 3E10 lead candidate confirmed
April 19, 2017
Appendix 4D - Half Year Accounts - 31 December 2016
February 22, 2017
Appendix 4C - Quarterly - 31 December 2016
January 17, 2017
Decks in 2017
- Shareholder Meeting (November 2017)
Shareholder meeting · 26 slides · Nov 23, 2017